Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The Protection Gap: Infection prevention and control Adherence and Determinants among SARS-CoV-2 Infected Healthcare Workers in Ethiopia and Implications for Future High-Consequence Pathogen Outbreaks

View through CrossRef
Abstract Background HCW (Health care workers) infections during outbreaks of high-consequence pathogens, from SARS-CoV-2 to Ethiopia's 2025–2026 Marburg outbreak, highlight persistent Infection Prevention and Control (IPC) gaps. Understanding the settings and determinants of adherence failure is essential to prepare for future outbreaks. Methods This cross-sectional study of 1,152 SARS-CoV-2-infected HCWs in Addis Ababa (March 2020–March 2021) assessed IPC adherence among HCWs with face-to-face or body fluid/surface exposure from suspected/confirmed patients within 14 days pre-diagnosis. Clinical environments categorized via adapted OSHA pyramid: High-Pathogen Designated Areas (HPDA: isolation/treatment), General High-Risk Areas (GHR: ICUs/EDs/ORs), Medium-Risk Clinical Areas (MRCA: inpatient/outpatient), Low-Risk Support Areas (LRS: administrative/non-clinical). Adherence (PPE use/hand hygiene/donning & doffing) defined as practice in >50% of interactions. Chi-square/Fisher’s exact tests and Cramér’s V assessed bivariate associations. Multivariable logistic regression identified determinants for donning/doffing (HCWs with face-to-face contact, N=742) and N95 seal checks (N=350, N95 users). Results Only 19.2% of infected HCWs worked in HPDA. Mask (85.7–97.7%) and glove (68.2–98.0%) adherence was high. Conversely, gowns, face shields/goggles, coveralls, head caps, N95, and shoe covers fell below 50%, except for face shields/goggles (52.8%) and N95 use during Aerosol Generating Procedures (AGPs) (66.5%). N95 seal‑check compliance was 34.9%; fit‑tested N95 use was 1.1%. Hand hygiene increased from 49.3% (before face‑to‑face) to 82.5% (after body fluid exposure). Per chi-square analysis, HPDA and health professionals had significantly better adherence than non-HPDA areas and support staff. For donning/doffing , odds were lower in non-HPDA areas (GHR aOR=0.12 [0.07–0.19]; MRCA aOR=0.08 [0.04–0.14]; LRS aOR=0.07 [0.03–0.17]). Adherence was higher with AGP involvement (aOR=3.61 [2.33–5.58]) and training (aOR=1.59 [1.05–2.41]), but lower among support staff (aOR=0.35 [0.14–0.88]). N95 seal-check odds were lower in non-HPDA areas (GHR aOR=0.53 [0.30–0.93]; MRCA aOR=0.33 [0.16–0.66]; LRS aOR=0.25 [0.08–0.77]). Positive predictors included communal living (aOR=2.37 [1.29–4.35]), IPC training (aOR=1.71 [1.03–2.83]), and AGP involvement (aOR=1.71 [1.05–2.80]), while age >30 (aOR=0.57 [0.34–0.98]) and stress (aOR=0.46 [0.28–0.77]) were negative determinants. Conclusions This study underscores IPC gaps among HCWs especially in non-designated areas, where most infections occurred, highlighting the need for standardized IPC across all healthcare environments.
Title: The Protection Gap: Infection prevention and control Adherence and Determinants among SARS-CoV-2 Infected Healthcare Workers in Ethiopia and Implications for Future High-Consequence Pathogen Outbreaks
Description:
Abstract Background HCW (Health care workers) infections during outbreaks of high-consequence pathogens, from SARS-CoV-2 to Ethiopia's 2025–2026 Marburg outbreak, highlight persistent Infection Prevention and Control (IPC) gaps.
Understanding the settings and determinants of adherence failure is essential to prepare for future outbreaks.
Methods This cross-sectional study of 1,152 SARS-CoV-2-infected HCWs in Addis Ababa (March 2020–March 2021) assessed IPC adherence among HCWs with face-to-face or body fluid/surface exposure from suspected/confirmed patients within 14 days pre-diagnosis.
Clinical environments categorized via adapted OSHA pyramid: High-Pathogen Designated Areas (HPDA: isolation/treatment), General High-Risk Areas (GHR: ICUs/EDs/ORs), Medium-Risk Clinical Areas (MRCA: inpatient/outpatient), Low-Risk Support Areas (LRS: administrative/non-clinical).
Adherence (PPE use/hand hygiene/donning & doffing) defined as practice in >50% of interactions.
Chi-square/Fisher’s exact tests and Cramér’s V assessed bivariate associations.
Multivariable logistic regression identified determinants for donning/doffing (HCWs with face-to-face contact, N=742) and N95 seal checks (N=350, N95 users).
Results Only 19.
2% of infected HCWs worked in HPDA.
Mask (85.
7–97.
7%) and glove (68.
2–98.
0%) adherence was high.
Conversely, gowns, face shields/goggles, coveralls, head caps, N95, and shoe covers fell below 50%, except for face shields/goggles (52.
8%) and N95 use during Aerosol Generating Procedures (AGPs) (66.
5%).
N95 seal‑check compliance was 34.
9%; fit‑tested N95 use was 1.
1%.
Hand hygiene increased from 49.
3% (before face‑to‑face) to 82.
5% (after body fluid exposure).
Per chi-square analysis, HPDA and health professionals had significantly better adherence than non-HPDA areas and support staff.
For donning/doffing , odds were lower in non-HPDA areas (GHR aOR=0.
12 [0.
07–0.
19]; MRCA aOR=0.
08 [0.
04–0.
14]; LRS aOR=0.
07 [0.
03–0.
17]).
Adherence was higher with AGP involvement (aOR=3.
61 [2.
33–5.
58]) and training (aOR=1.
59 [1.
05–2.
41]), but lower among support staff (aOR=0.
35 [0.
14–0.
88]).
N95 seal-check odds were lower in non-HPDA areas (GHR aOR=0.
53 [0.
30–0.
93]; MRCA aOR=0.
33 [0.
16–0.
66]; LRS aOR=0.
25 [0.
08–0.
77]).
Positive predictors included communal living (aOR=2.
37 [1.
29–4.
35]), IPC training (aOR=1.
71 [1.
03–2.
83]), and AGP involvement (aOR=1.
71 [1.
05–2.
80]), while age >30 (aOR=0.
57 [0.
34–0.
98]) and stress (aOR=0.
46 [0.
28–0.
77]) were negative determinants.
Conclusions This study underscores IPC gaps among HCWs especially in non-designated areas, where most infections occurred, highlighting the need for standardized IPC across all healthcare environments.

Related Results

The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract Introduction Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Mutations in SARS-CoV
Mutations in SARS-CoV
The coronavirus family is named for the large spike protein molecules found on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus genome is the bi...
Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare Workers
Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare Workers
ABSTRACT BACKGROUND The ongoing worldwide outbreak of the 2019-nCoV is markedly similar to the severe acute respiratory syndrom...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...

Back to Top